erythrodysesthesia

Mentioned in	?		References in periodicals archive	?		Medical browser	?		Full browser	?
5-fluorouracil 5-FU Adriamycin RDF Adrucil capecitabine clofarabine DOXOrubicin hydrochloride Efudex Fluoroplex fluorouracil lapatinib Nexavar palmar-plantar erythrodysesthesia syndrome palmoplantar erythrodysesthesia sorafenib sunitinib malate Sutent	5) While most commonly associated with chemotherapy agent toxicity, palmar/plantar erythrodysesthesia (PPE) or hand-foot syndrome (HFS) was initially described in association with sickle cell [beta]-thalassemia (13,14,15) and subsequently with sickle cell crisis. Hand-foot syndrome in a patient with multiple fire ant stings by Carr, Marcus E. / Southern Medical Journal The most frequently occurring Grade 3 and Grade 4 adverse events (>5%) regardless of relationship to drug were: fatigue, headache, palmar-plantar erythrodysesthesia, confusional state, alanine aminotransferase increase, convulsion, lymphopenia, hypophosphatemia, lipase increase, diarrhea, aspartate aminotransferase increase, and gait disturbance. Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 ... by Business Wire Adverse events of special interest were: hypertension (all incidences, 39%; Grade 3/4, 7%), palmar-plantar erythrodysesthesia (30%; 7%), bleeding events (28%; 9%), proteinuria (26%; 0%), pulmonary embolism (9%; 7%) and craniotomy wound dehiscence (4%; 2%). Exelixis and BMS Report Phase 2 Data to Be Presented at ASCO for ... by Business Wire	erythrocyte fragility erythrocyte fragility test erythrocyte indices erythrocyte reinfusion erythrocyte sedimentation rate Erythrocytes erythrocythemia erythrocytic erythrocytic series erythrocyto-opsonin erythrocytolysin erythrocytolysis erythrocytopenia erythrocytophagy erythrocytopoiesis erythrocytorrhexis erythrocytoschisis erythrocytosis erythrodegenerative erythroderma erythroderma desquamativum erythroderma polyneuropathy erythroderma psoriaticum erythrodermatitis erythrodontia erythrodysesthesia erythrodysesthesia syndrome erythrogenesis erythrogenesis imperfecta erythrogenic erythrogenic toxin erythrogenin erythrogonium erythrogram erythroid erythrokeratoderma erythrokeratoderma variabilis erythrokeratodermia erythrokinetics erythrolabe erythroleukemia erythroleukosis erythrolysin erythrolysis erythromelalgia erythromycin erythromycin ethylsuccinate erythromycin lactobionate erythromycin stearate Erythromycins erythromyeloblastic leukemia	erythrocytopoiesis erythrocytorrhexis erythrocytoschisis erythrocytosis erythrocytosis erythrocytosis erythrocytosis stimulating factor erythrocytosis stimulating factor erythrodegenerative erythroderma erythroderma erythroderma erythroderma desquamativum erythroderma desquamativum erythroderma desquamativum erythroderma polyneuropathy erythroderma psoriaticum erythroderma psoriaticum erythroderma psoriaticum erythrodermatitis erythrodermatitis erythrodermatitis erythrodermia Erythrodermic Autosomal Recessive Lamellar Ichthyosis Erythrodermic Inflammatory Skin Disease erythrodermic psoriasis erythrodermic psoriasis erythrodermic psoriasis Erythrodextrin erythrodontia erythrodysesthesia erythrodysesthesia syndrome Erythrogen erythrogenesis erythrogenesis imperfecta erythrogenic erythrogenic toxin erythrogenic toxin erythrogenic toxin erythrogenic toxin Erythrogenic Toxin type A erythrogenin erythrogonium erythrogram Erythrogranulose Erythrohepatic protoporphyria Erythrohepatic protoporphyria erythroid erythroid erythroid Erythroid - Associated Factor Erythroid 5-aminolevulinate synthetase deficiency Erythroid 5-aminolevulinate synthetase deficiency Erythroid 5-aminolevulinate synthetase deficiency erythroid aplasia erythroid aplasia erythroid cells erythroid cells erythroid cells erythroid cells Erythroid Denucleation Differentiation Factor

Mentioned in

References in periodicals archive

Medical browser

Full browser

5-fluorouracil
5-FU
Adriamycin RDF
Adrucil
capecitabine
clofarabine
DOXOrubicin hydrochloride
Efudex
Fluoroplex
fluorouracil
lapatinib
Nexavar
palmar-plantar erythrodysesthesia syndrome
palmoplantar erythrodysesthesia
sorafenib
sunitinib malate
Sutent

5) While most commonly associated with chemotherapy agent toxicity, palmar/plantar erythrodysesthesia (PPE) or hand-foot syndrome (HFS) was initially described in association with sickle cell [beta]-thalassemia (13,14,15) and subsequently with sickle cell crisis.

Hand-foot syndrome in a patient with multiple fire ant stings by Carr, Marcus E. / Southern Medical Journal

The most frequently occurring Grade 3 and Grade 4 adverse events (>5%) regardless of relationship to drug were: fatigue, headache, palmar-plantar erythrodysesthesia, confusional state, alanine aminotransferase increase, convulsion, lymphopenia, hypophosphatemia, lipase increase, diarrhea, aspartate aminotransferase increase, and gait disturbance.

Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 ... by Business Wire

Adverse events of special interest were: hypertension (all incidences, 39%; Grade 3/4, 7%), palmar-plantar erythrodysesthesia (30%; 7%), bleeding events (28%; 9%), proteinuria (26%; 0%), pulmonary embolism (9%; 7%) and craniotomy wound dehiscence (4%; 2%).

Exelixis and BMS Report Phase 2 Data to Be Presented at ASCO for ... by Business Wire

erythrocyte fragility

erythrocyte fragility test

erythrocyte indices

erythrocyte reinfusion

erythrocyte sedimentation rate